GTBPVSLQDA• 3 Months (Normalized)
GTBP vs LQDA (GT Biopharma Inc. vs Liquidia Corporation)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+1144.9%
GT Biopharma Inc.
Normalized Baseline0.00%
LQDA Performance $28.64
-63.84%
Liquidia Corporation
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1208.74 pts
GTBP outperforming by 1208.74 percentage points
GTBPLQDA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP LQDA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | GTBP Price | GTBP Gain (%) | LQDA Price | LQDA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +1144.90% | $28.64 | -63.84% | +1208.74% |
| Oct 01, 2026 | $- | $27.99 | -64.66% | - | |
| Sep 30, 2026 | $- | $30.26 | -61.80% | - | |
| Sep 29, 2026 | $6.88 | +1303.06% | $70.69 | -10.76% | +1313.82% |
| Sep 28, 2026 | $6.80 | +1287.76% | $73.67 | -6.99% | +1294.75% |
| Sep 25, 2026 | $6.89 | +1306.12% | $68.43 | -13.61% | +1319.73% |
| Sep 24, 2026 | $6.83 | +1293.88% | $70.95 | -10.43% | +1304.31% |
| Sep 23, 2026 | $7.10 | +1348.98% | $67.49 | -14.80% | +1363.78% |
| Sep 22, 2026 | $- | $68.64 | -13.34% | - | |
| Sep 21, 2026 | $7.18 | +1365.31% | $66.43 | -16.13% | +1381.44% |
| Sep 18, 2026 | $7.16 | +1361.22% | $66.88 | -15.57% | +1376.79% |
| Sep 17, 2026 | $7.49 | +1428.57% | $68.39 | -13.66% | +1442.23% |
| Sep 16, 2026 | $7.81 | +1493.88% | $68.45 | -13.58% | +1507.46% |
| Sep 15, 2026 | $9.00 | +1736.73% | $65.72 | -17.03% | +1753.76% |
| Sep 14, 2026 | $11.63 | +2273.47% | $65.31 | -17.55% | +2291.02% |
Page 1 of 5